The onset of vitiligo and its subsequent progression is thought to be impelled by several inherited genes and can develop at any age irrespective of the type of skin, gender, race, or geographical location
This insulin resistance disrupts SC and axon metabolism, diverting glycolytic intermediates into the polyol and hexosamine pathways
Users typically achieve 10-15% weight loss during this period, with continued improvement in metabolic markers and overall health
Guidance on strategies to minimize GI adverse events in women is largely empirical
The FDA has approved Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, when used with a reduced-calorie diet and increased physical activity
Protecting it requires deliberate action